患有的儿童的药物遵守:一个横截面调查
Shanshan Wang1, Xu Zhang1, Yongqian Wang1
1Department of Neurology, Children's Hospital of Nanjing Medical University, No. 72, Guangzhou Road, Gulou District, Nanjing, Jiangsu Province, China.
患有的儿童的药物服药通常很差,影响了预后. 诸如年龄,的持续时间,父母的教育,收入和药物的数量等因素会影响遵守,需要有针对性的干预措施.
科学领域:
- 儿科神经学 儿科神经学
- 临床药房 临床药房
- 公共卫生 公共卫生
背景情况:
- 服药对患有的儿童的长期健康结果至关重要.
- 不良的坚持可以显著恶化儿科患者的预后和生活质量.
研究的目的:
- 评估患者儿童药物服药的现状.
- 确定影响该群体药物坚持的关键因素.
- 为改善儿科管理提供临床护理实践的信息.
主要方法:
- 这项研究涉及156名被送往儿童医院的儿童.
- 使用自行设计的问卷和药物合规度量表.
- 采用皮尔森相关性和多变量逻辑回归分析来确定影响因素.
主要成果:
- 37.18%的儿童表现出不良的药物服药.
- 在服药和年龄,持续时间,父母教育,收入和药物数量之间发现了显著的相关性.
- 年龄较小,持续时间较长,父母教育程度较低,收入较低和多药性与不良合规性有关.
结论:
- 患有的儿童的药物服药需要改进.
- 关键影响因素包括患者年龄,持续时间,社会经济地位和治疗复杂性.
- 针对这些因素的有针对性的护理干预措施对于提高药物坚持是必不可少的.
更多相关视频
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Factors Affecting Drug Response: Overview
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
